146 related articles for article (PubMed ID: 22495710)
1. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival.
Liu Y; Li Q; Zhu L
Tumori; 2012; 98(1):105-12. PubMed ID: 22495710
[TBL] [Abstract][Full Text] [Related]
2. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
[TBL] [Abstract][Full Text] [Related]
3. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
Yang L; Guo T; Jiang S; Yang Z
Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma.
Oda Y; Sakamoto A; Saito T; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Feb; 31(2):185-92. PubMed ID: 10685632
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatocyte growth factor and c-met in ulcerative colitis.
Kitamura S; Kondo S; Shinomura Y; Isozaki K; Kanayama S; Higashimoto Y; Minami T; Kiyohara T; Yasunaga Y; Ishikawa H; Ohtani T; Ishiguro S; Matsuzawa Y
Inflamm Res; 2000 Jul; 49(7):320-4. PubMed ID: 10959552
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
8. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
[TBL] [Abstract][Full Text] [Related]
9. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.
Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R
Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and c-met receptor in gastric mucosa during gastric ulcer healing.
Hori K; Shiota G; Kawasaki H
Scand J Gastroenterol; 2000 Jan; 35(1):23-31. PubMed ID: 10672830
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
Parr C; Jiang WG
Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
[TBL] [Abstract][Full Text] [Related]
18. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
19. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients.
Masuya D; Huang C; Liu D; Nakashima T; Kameyama K; Haba R; Ueno M; Yokomise H
Br J Cancer; 2004 Apr; 90(8):1555-62. PubMed ID: 15083185
[TBL] [Abstract][Full Text] [Related]
20. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
Ang CS; Sun MY; Huitzil-Melendez DF; Chou JF; Capanu M; Jarnagin W; Fong Y; Dematteo RP; D'Angelica M; Allen P; Chen CT; O'Reilly EM; Weiser MR; Abou-Alfa GK
Anticancer Res; 2013 Aug; 33(8):3241-5. PubMed ID: 23898085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
